BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23001279)

  • 1. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
    Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
    J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Medicare Part D coverage gap on medication adherence.
    Zhang Y; Baik SH; Lave JR
    Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
    Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
    Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic initiation and antidepressant therapy adherence under Medicare Part D.
    Bao Y; Ryan AM; Shao H; Pincus HA; Donohue JM
    Am J Manag Care; 2013 Dec; 19(12):989-98. PubMed ID: 24512035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the medication coverage gap on seniors with co-occurring depression and heart failure.
    Moscarelli M; Manning W
    J Ment Health Policy Econ; 2012 Sep; 15(3):103-4. PubMed ID: 23012766
    [No Abstract]   [Full Text] [Related]  

  • 8. Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.
    Zhang Y; Baik SH
    J Gen Intern Med; 2014 Apr; 29(4):602-7. PubMed ID: 24366395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.
    Stuart B; Davidoff A; Erten M; Gottlieb SS; Dai M; Shaffer T; Zuckerman IH; Simoni-Wastila L; Bryant-Comstock L; Shenolikar R
    Health Serv Res; 2013 Dec; 48(6 Pt 1):1960-77. PubMed ID: 23742013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare Part D and quality of prescription medication use in older adults.
    Lau DT; Briesacher BA; Touchette DR; Stubbings J; Ng JH
    Drugs Aging; 2011 Oct; 28(10):797-807. PubMed ID: 21970307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.
    Stuart B; Yin X; Davidoff A; Simoni-Wastila L; Zuckerman I; Shoemaker JS; Doshi J
    Med Care; 2012 Nov; 50(11):913-9. PubMed ID: 23047779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects by Mental Health Status of Filling the Medicare Part D Coverage Gap.
    Liu J; Zhang Y; Kaplan CM
    Med Care; 2022 Feb; 60(2):133-139. PubMed ID: 35030562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticipatory Behavior in Response to Medicare Part D's Coverage Gap.
    Kaplan CM; Zhang Y
    Health Econ; 2017 Mar; 26(3):338-351. PubMed ID: 26749399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression.
    Donohue JM; Zhang Y; Aiju M; Perera S; Lave JR; Hanlon JT; Reynolds CF
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):989-97. PubMed ID: 22123272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?
    Sacks NC; Burgess JF; Cabral HJ; McDonnell ME; Pizer SD
    J Manag Care Spec Pharm; 2015 Aug; 21(8):678-87. PubMed ID: 26233540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
    Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.
    McGee BT; Phillips V; Higgins MK; Butler J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):705-713. PubMed ID: 31134861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.